Related Experiment Video
Updated: Jan 9, 2026

05:22
Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
1.7K
Clinical Profile, Management and Visual Outcomes in Patients with Sarcoid Posterior Uveitis
Ayushi Mohapatra1, Rajiv Raman1, Janakiraman Palani2
1Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, India.
Ocular Immunology and Inflammation
|December 3, 2025
Summary
Sarcoid posterior uveitis (SPU) can cause vision loss. Early diagnosis and treatment with steroids and immunosuppressives (IMT) improve outcomes, with prognosis varying by lesion type.
Area of Science:
- Ophthalmology
- Immunology
Background:
- Sarcoid posterior uveitis (SPU) is a significant cause of visual morbidity.
- Understanding its demographic profile, clinical features, and outcomes is crucial for effective management.
Purpose of the Study:
- To determine the demographic profile, clinical features, investigative results, management, lesion-specific outcomes, complications, and follow-up of diagnosed sarcoid posterior uveitis (SPU) cases.
- To analyze lesion-specific visual prognosis and clinical response to treatment in SPU patients.
Main Methods:
- A retrospective observational study was conducted.
- Data from SPU cases were extracted from electronic medical records at a tertiary care center in India.
Main Results:
- Seventy-two eyes of 43 patients were analyzed, with choroidal granulomas being the most common lesion (62%).
- Steroids and immunosuppressives (IMT) were the primary treatments. Visual acuity (BCVA) was stable in 75% of followed eyes.
- Outcomes were better for retinal vasculitis and choroidal granulomas compared to multifocal choroiditis.
Conclusions:
- Sarcoid posterior uveitis is linked to considerable visual morbidity.
- Prompt identification and treatment with steroids and IMT can lead to uveitis resolution and vision improvement.
- The visual prognosis and treatment response are dependent on the specific lesion subtype of SPU.
More Related Videos
Related Concept Videos
Open Angle Glaucoma: Treatment
934
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
934
Glaucoma: Overview
1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
Nephrotic Syndrome II : Assessment and Medical Management
184
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
184

